Skip to main content
Figure 4 | Clinical and Molecular Allergy

Figure 4

From: Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity

Figure 4

IgE reactivity of patient sera. IgE reactivity of individual patient sera from double-positive (A) or YJV-positive patients (B) to rVes v 1 and rVes v 5 produced in Sf9 insect cells, nApi m 1, and MUXF-BSA. The cut-off of the ELISA is indicated by a dashed line (mean background plus two fold the SD). The percentage of sIgE reactivity to either each allergen (Ves v 1 only/Ves v 5 only) or both allergens (Ves v 1 and Ves v 5) is represented in C for double-positive (black bars) or YJV-positive (grey bars) patients. The overall sIgE reactivity to Ves v 1 or Ves v 5 (sum Ves v 1 or sum Ves v 5) was obtained by addition of exclusive sIgE reactivity to one allergen to sIgE reactivity if not recognized exclusively. Overall diagnostic sensitivity (sum) was obtained by addition of all sIgE reactivities.

Back to article page

Clinical and Molecular Allergy

ISSN: 1476-7961

Contact us